October 20, 2025 - 18:56

The New Hampshire Department of Justice has imposed fines on key Republican figures in the state House of Representatives, along with the sole Democrat on the Executive Council, due to violations related to campaign finance. Cease-and-desist letters were issued on Friday, highlighting the seriousness of the infractions.
Among those fined is Republican House Majority Leader Jason Osborne, who has faced scrutiny over his campaign financing practices. Additionally, Executive Councilor Karen Liot Hill and Deputy Majority House Leader Joe Sweeney were also named in the correspondence from the DOJ. The letters outline specific breaches of campaign finance laws, which are designed to ensure transparency and fairness in political funding.
These penalties reflect ongoing efforts by state authorities to enforce compliance with campaign finance regulations. As the political landscape continues to evolve, such actions underscore the importance of adhering to established guidelines to maintain the integrity of the electoral process in New Hampshire.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...